70 results
Page 2 of 4
8-K
EX-1.1
fvxhlqo317uysn
5 Oct 23
Other Events
4:05pm
424B5
ovv3pv
4 Oct 23
Prospectus supplement for primary offering
4:05pm
8-K
EX-1.1
myfl5
2 Oct 23
Other Events
9:41pm
424B5
zqdl2b5b
2 Oct 23
Prospectus supplement for primary offering
5:09pm
424B5
i5e1rfr19ksv8tigwk
2 Oct 23
Prospectus supplement for primary offering
5:07pm
S-3ASR
EX-4.1
uydgq
2 Oct 23
Automatic shelf registration
4:01pm
S-3ASR
0apwaj9t
2 Oct 23
Automatic shelf registration
4:01pm
8-K
EX-99.1
cd98n 1mpyoe4ncln43
31 Jul 23
Biohaven Reports Second Quarter 2023 Financial Results and Recent Business Developments
4:29pm
8-K
EX-99.1
ojzcaqmxq5wzg ps
28 Jul 23
Biohaven Provides Preliminary EEG Data Update for Kv7 Platform, Regulatory Update on Troriluzole and Other Corporate Updates
4:35pm
8-K
EX-99.1
7kk2n4tdxkrrm2r48t
31 May 23
Biohaven Provides Overview of Clinical Progress, Regulatory Updates, and Pipeline Developments at R&D Day
7:03am
10-Q
fuk2q
9 Nov 22
Quarterly report
4:19pm
10-Q
EX-10.18
0psv9a6ea9i5
9 Nov 22
Quarterly report
4:19pm
424B4
ry9qdmhsc5b
24 Oct 22
Prospectus supplement with pricing info
9:38am
S-1/A
12em3j so
20 Oct 22
IPO registration (amended)
10:00am
S-1
EX-1.1
07jegob
18 Oct 22
IPO registration
4:03pm
S-1
eo61v ivn4t8
18 Oct 22
IPO registration
4:03pm